CN108517014A - 利培酮半抗原的抗体及其用途 - Google Patents
利培酮半抗原的抗体及其用途 Download PDFInfo
- Publication number
- CN108517014A CN108517014A CN201810382955.6A CN201810382955A CN108517014A CN 108517014 A CN108517014 A CN 108517014A CN 201810382955 A CN201810382955 A CN 201810382955A CN 108517014 A CN108517014 A CN 108517014A
- Authority
- CN
- China
- Prior art keywords
- antibody
- risperidone
- group
- sample
- bound
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 0 C[C@](C1N2CCCC1*)C(C)=C(CCN(CC1)CCC1C1=NOCC1=CC=C(C)*)[C@@]2O Chemical compound C[C@](C1N2CCCC1*)C(C)=C(CCN(CC1)CCC1C1=NOCC1=CC=C(C)*)[C@@]2O 0.000 description 4
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
- C07K16/44—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material not provided for elsewhere, e.g. haptens, metals, DNA, RNA, amino acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/94—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving narcotics or drugs or pharmaceuticals, neurotransmitters or associated receptors
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2800/00—Detection or diagnosis of diseases
- G01N2800/30—Psychoses; Psychiatry
- G01N2800/302—Schizophrenia
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Molecular Biology (AREA)
- Immunology (AREA)
- Medicinal Chemistry (AREA)
- Biomedical Technology (AREA)
- General Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biochemistry (AREA)
- Hematology (AREA)
- Urology & Nephrology (AREA)
- Pharmacology & Pharmacy (AREA)
- Biophysics (AREA)
- Physics & Mathematics (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Genetics & Genomics (AREA)
- Pathology (AREA)
- General Physics & Mathematics (AREA)
- Biotechnology (AREA)
- Cell Biology (AREA)
- Analytical Chemistry (AREA)
- Food Science & Technology (AREA)
- Microbiology (AREA)
- Veterinary Medicine (AREA)
- General Chemical & Material Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Neurology (AREA)
- Public Health (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Psychiatry (AREA)
- Neurosurgery (AREA)
- Pain & Pain Management (AREA)
- Peptides Or Proteins (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201261691615P | 2012-08-21 | 2012-08-21 | |
| US61/691615 | 2012-08-21 | ||
| CN201380054952.5A CN104736565B (zh) | 2012-08-21 | 2013-08-20 | 利培酮半抗原的抗体及其用途 |
Related Parent Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN201380054952.5A Division CN104736565B (zh) | 2012-08-21 | 2013-08-20 | 利培酮半抗原的抗体及其用途 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN108517014A true CN108517014A (zh) | 2018-09-11 |
Family
ID=50148308
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN201810382955.6A Pending CN108517014A (zh) | 2012-08-21 | 2013-08-20 | 利培酮半抗原的抗体及其用途 |
| CN201380054952.5A Active CN104736565B (zh) | 2012-08-21 | 2013-08-20 | 利培酮半抗原的抗体及其用途 |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN201380054952.5A Active CN104736565B (zh) | 2012-08-21 | 2013-08-20 | 利培酮半抗原的抗体及其用途 |
Country Status (10)
| Country | Link |
|---|---|
| US (3) | US9751953B2 (cg-RX-API-DMAC7.html) |
| EP (1) | EP2888284B1 (cg-RX-API-DMAC7.html) |
| JP (3) | JP6374387B2 (cg-RX-API-DMAC7.html) |
| CN (2) | CN108517014A (cg-RX-API-DMAC7.html) |
| AU (3) | AU2013305884B2 (cg-RX-API-DMAC7.html) |
| CA (1) | CA2882563C (cg-RX-API-DMAC7.html) |
| ES (1) | ES2926662T3 (cg-RX-API-DMAC7.html) |
| PL (1) | PL2888284T3 (cg-RX-API-DMAC7.html) |
| PT (1) | PT2888284T (cg-RX-API-DMAC7.html) |
| WO (1) | WO2014031645A1 (cg-RX-API-DMAC7.html) |
Cited By (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN112608310A (zh) * | 2020-12-17 | 2021-04-06 | 北京丹大生物技术有限公司 | 一种利培酮和9-羟基利培酮半抗原、抗原和抗体以及其应用 |
| CN113424060A (zh) * | 2019-01-31 | 2021-09-21 | 美国西门子医学诊断股份有限公司 | 抗纳洛酮和抗纳曲酮单克隆抗体及其生产和使用方法 |
| CN116003404A (zh) * | 2022-12-14 | 2023-04-25 | 杭州同舟生物技术有限公司 | 一种利培酮人工半抗原、人工抗原及其制备方法和应用 |
Families Citing this family (19)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| PL2888286T3 (pl) | 2012-08-21 | 2018-07-31 | Janssen Pharmaceutica Nv | Przeciwciała skierowane przeciwko haptenom kwetiapinowym i ich zastosowanie |
| AU2013305970B2 (en) | 2012-08-21 | 2017-08-17 | Saladax Biomedical Inc. | Antibodies to aripiprazole haptens and use thereof |
| EP2888277A4 (en) | 2012-08-21 | 2016-05-18 | Ortho Clinical Diagnostics Inc | ANTIBODIES AGAINST PALIPERIDONE AND USE THEREOF |
| ES2870004T3 (es) * | 2012-08-21 | 2021-10-26 | Janssen Pharmaceutica Nv | Anticuerpos contra la risperidona y uso de los mismos |
| ES2654413T3 (es) | 2012-08-21 | 2018-02-13 | Janssen Pharmaceutica, N.V. | Anticuerpos a quetiapina y uso de los mismos |
| AU2013305930B2 (en) | 2012-08-21 | 2017-08-24 | Saladax Biomedical Inc. | Haptens of paliperidone |
| ES3057437T3 (en) | 2012-08-21 | 2026-03-02 | Janssen Pharmaceutica Nv | Antibodies to olanzapine haptens and use thereof |
| WO2014031645A1 (en) | 2012-08-21 | 2014-02-27 | Ortho-Clinical Diagnostics, Inc | Antibodies to risperidone haptens and use thereof |
| WO2014031662A2 (en) | 2012-08-21 | 2014-02-27 | Ortho-Clinical Diagnostics, Inc | Antibodies to olanzapine and use thereof |
| JP2015529199A (ja) * | 2012-08-21 | 2015-10-05 | オルソ−クリニカル ダイアグノスティクス,インコーポレイティド | パリペリドンハプテンに対する抗体及びその使用 |
| WO2014031584A1 (en) | 2012-08-21 | 2014-02-27 | Janssen Pharmaceutica Nv | Haptens of aripiprazole and their use in immunoassays |
| PL2888373T3 (pl) | 2012-08-21 | 2018-08-31 | Janssen Pharmaceutica Nv | Przeciwciała dla arypiprazolu i ich zastosowanie |
| JP6523020B2 (ja) * | 2015-03-31 | 2019-05-29 | 古河電気工業株式会社 | 生体分子の検出又は定量方法、及び生体分子の検出又は定量用標識試薬粒子 |
| CN108368180B (zh) | 2015-12-17 | 2022-07-26 | 詹森药业有限公司 | 喹硫平的抗体及其用途 |
| JP6949025B2 (ja) | 2015-12-17 | 2021-10-13 | ヤンセン ファーマシューティカ エヌ.ベー. | リスペリドンに対する抗体及びその使用 |
| CN110938072A (zh) * | 2019-10-30 | 2020-03-31 | 杭州博拓生物科技股份有限公司 | 一种利培酮人工抗原及其制备方法 |
| CN111808046B (zh) * | 2020-06-30 | 2022-11-11 | 杭州同舟生物技术有限公司 | 一种喹硫平人工半抗原、人工抗原及其制备方法和应用 |
| CN114685470B (zh) * | 2020-12-25 | 2023-08-18 | 长沙博源医疗科技有限公司 | 一种利培酮关键基团衍生物、免疫原、抗利培酮特异性抗体及其制备方法与应用 |
| US11977085B1 (en) | 2023-09-05 | 2024-05-07 | Elan Ehrlich | Date rape drug detection device and method of using same |
Citations (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO1999040934A1 (en) * | 1998-02-12 | 1999-08-19 | Immune Complex, Corporation | Strategically modified hepatitis b core proteins and their derivatives |
| CN1496974A (zh) * | 2002-01-31 | 2004-05-19 | ʵ | 氯胺酮和其代谢物的半抗原、免疫原、抗体和偶联物 |
| CN101147063A (zh) * | 2005-02-08 | 2008-03-19 | 萨拉戴克斯生物医学公司 | 5-氟-尿嘧啶免疫测定 |
| JP2008094729A (ja) * | 2006-10-06 | 2008-04-24 | Osaka Prefecture Univ | ハプテン化合物および抗体 |
| CN101987836A (zh) * | 2010-08-31 | 2011-03-23 | 华南农业大学 | 氯丙嗪半抗原、人工抗原和抗体及其制备方法和应用 |
| US20110229979A1 (en) * | 2010-03-16 | 2011-09-22 | Salamone Salvatore J | Risperidone immunoassay |
Family Cites Families (110)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4022780A (en) | 1973-03-06 | 1977-05-10 | Imperial Chemical Industries Limited | Process for the manufacture of indole derivatives |
| US4166452A (en) | 1976-05-03 | 1979-09-04 | Generales Constantine D J Jr | Apparatus for testing human responses to stimuli |
| US4804663A (en) * | 1985-03-27 | 1989-02-14 | Janssen Pharmaceutica N.V. | 3-piperidinyl-substituted 1,2-benzisoxazoles and 1,2-benzisothiazoles |
| US5576195A (en) | 1985-11-01 | 1996-11-19 | Xoma Corporation | Vectors with pectate lyase signal sequence |
| US6893625B1 (en) | 1986-10-27 | 2005-05-17 | Royalty Pharma Finance Trust | Chimeric antibody with specificity to human B cell surface antigen |
| ES2150428T3 (es) | 1987-04-27 | 2000-12-01 | Unilever Nv | Ensayos de union especifica. |
| US5120643A (en) | 1987-07-13 | 1992-06-09 | Abbott Laboratories | Process for immunochromatography with colloidal particles |
| AU2684488A (en) | 1988-06-27 | 1990-01-04 | Carter-Wallace, Inc. | Test device and method for colored particle immunoassay |
| JPH04507244A (ja) * | 1989-07-27 | 1992-12-17 | ユニバックス・バイオロジクス・インコーポレイテッド | リピドa類似体/免疫原性担体コンジュゲートおよびそのワクチンとしての使用 |
| US5252496A (en) | 1989-12-18 | 1993-10-12 | Princeton Biomeditech Corporation | Carbon black immunochemical label |
| EP0517327B1 (en) | 1991-06-07 | 2001-08-16 | Johnson & Johnson Clinical Diagnostics, Inc. | Immunoassay with labeled hapten analogues |
| FI941572L (fi) | 1991-10-07 | 1994-05-27 | Oncologix Inc | Anti-erbB-2-monoklonaalisten vasta-aineiden yhdistelmä ja käyttömenetelmä |
| US5616505A (en) | 1992-03-27 | 1997-04-01 | Abbott Laboratories | Haptens tracers, immunogens and antibodies for 3-phenyl-1-adamantaneacetic acids |
| US6034078A (en) | 1992-05-29 | 2000-03-07 | Eli Lilly And Company Limited | Thienobenzodiazepine compounds |
| DE69329887T2 (de) | 1992-05-29 | 2001-05-23 | Eli Lilly And Co., Ltd. | Thienobenzodiazepinderivate zur Behandlung von Störungen des Zentralnervensystems |
| US5527709A (en) | 1992-06-26 | 1996-06-18 | Johnson & Johnson Clinical Diagnostics, Inc. | Immunoassays with labeled thyronine hapten analogues |
| US5642870A (en) | 1992-08-05 | 1997-07-01 | Sargis; Ike | Switch stand |
| US5395933A (en) | 1992-08-07 | 1995-03-07 | Eastman Kodak Company | Carbamazepine hapten analogues |
| ATE288270T1 (de) | 1993-11-19 | 2005-02-15 | Janssen Pharmaceutica Nv | Mikroverkapselte 1,2-benzazole |
| WO1995034652A1 (en) | 1994-06-10 | 1995-12-21 | Oklahoma Medical Research Foundation | Calcium binding recombinant antibody against protein c |
| EG23659A (en) | 1995-03-24 | 2007-03-26 | Lilly Co Eli | Process and crystal forms of methyl-thieno-benzodiazepine |
| US5641870A (en) | 1995-04-20 | 1997-06-24 | Genentech, Inc. | Low pH hydrophobic interaction chromatography for antibody purification |
| US5643933A (en) | 1995-06-02 | 1997-07-01 | G. D. Searle & Co. | Substituted sulfonylphenylheterocycles as cyclooxygenase-2 and 5-lipoxygenase inhibitors |
| US5761894A (en) | 1996-09-25 | 1998-06-09 | Magic Circle Corporation | Grass striping attachment for lawn mowers |
| AU8148898A (en) | 1997-06-23 | 1999-01-04 | Luminex Corporation | Interlaced lasers for multiple fluorescence measurement |
| US6830731B1 (en) | 1998-01-05 | 2004-12-14 | Biosite, Inc. | Immunoassay fluorometer |
| US6362371B1 (en) * | 1998-06-08 | 2002-03-26 | Advanced Medicine, Inc. | β2- adrenergic receptor agonists |
| US20030143233A1 (en) | 1999-06-07 | 2003-07-31 | Neorx Corporation | Streptavidin expressed gene fusions and methods of use thereof |
| RU2181297C2 (ru) | 2000-06-20 | 2002-04-20 | Эпштейн Олег Ильич | Способ лечения патологического синдрома и лекарственное средство |
| US7163681B2 (en) * | 2000-08-07 | 2007-01-16 | Centocor, Inc. | Anti-integrin antibodies, compositions, methods and uses |
| US6958156B2 (en) | 2000-12-15 | 2005-10-25 | Vyrex Corporation | Isoflavone derivatives |
| EP1476120B1 (en) | 2002-02-21 | 2010-09-29 | Duke University | Treatment methods using anti-cd22 antibodies |
| EP2316468A1 (en) | 2002-02-22 | 2011-05-04 | Shire LLC | Delivery system and methods for protecting and administering dextroamphetamine |
| CA2478047C (en) | 2002-03-01 | 2014-01-21 | Immunomedics, Inc. | Rs7 antibodies |
| EP1492794B1 (en) | 2002-03-28 | 2007-12-12 | Eli Lilly And Company | Piperazine substituted aryl benzodiazepines and their use as dopamine receptor antagonists for the treatment of psychotic disorders |
| SE0201738D0 (sv) | 2002-06-07 | 2002-06-07 | Aamic Ab | Micro-fluid structures |
| CA2494109A1 (en) | 2002-07-29 | 2004-02-05 | Potomac, Pharma, Llc. | Antipsychotic combination therapies and compositions of an alpha-2 adrenergic receptor antagonist and an atypical antipsychotic neuroleptic |
| ES2285227T3 (es) | 2002-08-05 | 2007-11-16 | Eli Lilly And Company | Arilbenzodiazepinas sustituidas con piperazina. |
| EP1562984B1 (de) * | 2002-11-20 | 2006-08-09 | B.R.A.H.M.S Aktiengesellschaft | Sandwich-immunoassay zur bestimmung von proanp-teilpeptiden |
| US20040193446A1 (en) | 2003-03-27 | 2004-09-30 | Mayer Steven Lloyd | System and method for managing a patient treatment program including a prescribed drug regimen |
| US7271252B2 (en) | 2003-04-22 | 2007-09-18 | Roche Diagnostics Operations, Inc. | Reagents for detecting efavirenz |
| KR101351122B1 (ko) | 2003-05-09 | 2014-01-14 | 듀크 유니버시티 | Cd20-특이적 항체 및 이를 이용한 방법 |
| CA2536073A1 (en) * | 2003-08-18 | 2005-02-24 | H. Lundbeck A/S | Trans-1(6-chloro-3-phenylindan-1-yl)-3,3-dimethylpiperazine |
| PT1664007E (pt) | 2003-09-23 | 2010-02-15 | Fermion Oy | Preparação de quetiapina |
| KR20140015122A (ko) | 2003-10-01 | 2014-02-06 | 아돌로 코포레이션 | 스피로시클릭 헤테로시클릭 유도체 및 이의 사용 방법 |
| BRPI0415531B8 (pt) | 2003-10-23 | 2021-05-25 | Otsuka Pharma Co Ltd | formulação de aripiprazol injetável estéril de liberação controlada e método para a sua preparação |
| DE602004024236D1 (en) * | 2003-12-12 | 2009-12-31 | Inverness Medical Switzerland | Assay |
| SE0400662D0 (sv) | 2004-03-24 | 2004-03-24 | Aamic Ab | Assay device and method |
| WO2005103250A1 (ja) | 2004-04-26 | 2005-11-03 | Takami Matsuyama | 葉酸リセプターベータ(FR-β)に対する単クローン抗体を含有する治療薬 |
| US7087699B2 (en) | 2004-05-17 | 2006-08-08 | Acushnet Company | Sulfur-containing composition for golf equipment, and method of using same |
| SE527036C2 (sv) | 2004-06-02 | 2005-12-13 | Aamic Ab | Analysanordning med reglerat flöde och motsvarande förfarande |
| TW200616604A (en) | 2004-08-26 | 2006-06-01 | Nicholas Piramal India Ltd | Nitric oxide releasing prodrugs containing bio-cleavable linker |
| US20060235005A1 (en) | 2005-04-14 | 2006-10-19 | Oak Labs, Corp. | Use of phosphodiesterase 5 (PDE5) inhibitors in the treatment of schizophrenia |
| CN101163702B (zh) | 2005-04-25 | 2011-09-07 | 詹森药业有限公司 | 制备无菌的3-[2-[4-(6-氟-1,2-苯并异唑-3-基)-1-哌啶基]乙基]-6,7,8,9-四氢-9-羟基-2-甲基-4H-吡啶并[1,2-a]嘧啶-4-酮棕榈酸酯的方法 |
| SE529254C2 (sv) | 2005-06-17 | 2007-06-12 | Aamic Ab | Optiskt testsystem |
| SE528233C2 (sv) | 2005-06-20 | 2006-09-26 | Aamic Ab | Metod och medel för att åstadkomma vätsketransport |
| SE529711C2 (sv) | 2006-03-22 | 2007-11-06 | Aamic Ab | Fluorescensläsare |
| US8975374B2 (en) | 2006-10-20 | 2015-03-10 | Chugai Seiyaku Kabushiki Kaisha | Pharmaceutical composition comprising anti-HB-EGF antibody as active ingredient |
| JP5378795B2 (ja) | 2006-10-20 | 2013-12-25 | 中外製薬株式会社 | 抗hb−egf抗体を有効成分として含む医薬組成物 |
| EP2077860B1 (en) | 2006-10-25 | 2014-04-09 | Ramot at Tel-Aviv University Ltd | Psychotropic agents having glutamate nmda activity |
| US20080138842A1 (en) | 2006-12-11 | 2008-06-12 | Hans Boehringer | Indirect lateral flow sandwich assay |
| ES2405364T3 (es) | 2006-12-29 | 2013-05-30 | Abbott Laboratories | Ensayo diagnóstico para la detección de una molécula o fármaco en sangre entera |
| WO2008087557A2 (en) | 2007-01-08 | 2008-07-24 | Actavis Group Ptc Ehf | An improved process for preparation of 9-hydroxy-3-(2-chloroethyl)- 2-methyl-4h-pyrido[1,2-a]pyrimidin-4-one hydrochloride |
| CN101245065B (zh) | 2007-02-14 | 2010-05-19 | 江苏恩华药业股份有限公司 | 制备苯并异噁唑衍生物的方法及其中间体 |
| JP2010540920A (ja) | 2007-09-27 | 2010-12-24 | ノバルティス アーゲー | 薬物モニタリングアッセイ |
| KR101706789B1 (ko) | 2008-07-21 | 2017-02-14 | 프로비오드룩 아게 | 진단용 항체 검사법 |
| MX2011001384A (es) | 2008-08-06 | 2011-09-27 | Gosforth Ct Holdings Pty Ltd | Composiciones y metodos para tratar trastornos psiquiatricos. |
| WO2010033270A1 (en) | 2008-09-17 | 2010-03-25 | Auspex Pharmaceuticals, Inc. | Dibenzothiazepine modulators of dopamine, alpha adrenergic, and serotonin receptors |
| TW201020258A (en) | 2008-10-14 | 2010-06-01 | Astrazeneca Ab | Chemical compounds 542 |
| WO2010096117A2 (en) * | 2008-10-29 | 2010-08-26 | Janssen Pharmaceutica Nv | Methods of treating psychosis and schizophrenia based on polymorphisms in the erbb4 gene |
| EP2194048A1 (en) | 2008-12-02 | 2010-06-09 | Dirk Sartor | Nitrate esters for the treatment of vascular and metabolic diseases |
| US8480333B2 (en) | 2008-12-26 | 2013-07-09 | Steven Edward DeMay | Frame rail assemblies and interlocking frame rail systems |
| NZ594071A (en) * | 2009-01-26 | 2013-01-25 | Egalet Ltd | Controlled release formulations comprising morphine sulphate for continuous treatment of pain |
| BRPI1009454A2 (pt) | 2009-03-10 | 2019-09-24 | Baylor Res Institute | vacinas contra o câncer direcionadas a células apresentadoras de antígenos |
| JP5732453B2 (ja) | 2009-06-25 | 2015-06-10 | アルカーメス ファーマ アイルランド リミテッド | Nh酸性化合物のプロドラッグ |
| LT2459220T (lt) | 2009-07-31 | 2020-12-28 | Ascendis Pharma A/S | Biologiškai suyrantys vandenyje netirpūs hidrogeliai polietilenglikolio pagrindu |
| US20120282173A1 (en) | 2009-08-17 | 2012-11-08 | Forerunner Pharma Research Co., Ltd. | Pharmaceutical composition comprising anti-hb-egf antibody as active ingredient |
| US8076097B2 (en) | 2009-08-19 | 2011-12-13 | Saladax Biomedical Inc. | Imatinib immunoassay |
| US20130053405A1 (en) | 2009-10-06 | 2013-02-28 | Ulrich Hersel | Carrier linked paliperidone prodrugs |
| EP2343296A1 (en) | 2009-12-01 | 2011-07-13 | Chemo Ibérica, S.A. | A process for the purification of paliperidone |
| CN107714703A (zh) | 2009-12-31 | 2018-02-23 | 凯姆制药公司 | 喹硫平的氨基酸缀合物、其制备和使用方法 |
| RS58335B1 (sr) | 2010-03-11 | 2019-03-29 | Kempharm Inc | Konjugati kvetiapina sa masnom kiselinom, proces za njihovo dobijanje i njihova primena |
| US8114621B2 (en) | 2010-03-12 | 2012-02-14 | Saladax Biomedical Inc. | Lenalidomide and thalidomide immunoassays |
| WO2011159537A2 (en) | 2010-06-15 | 2011-12-22 | The Regents Of The University Of California | Method and device for analyte detection |
| US8530413B2 (en) | 2010-06-21 | 2013-09-10 | Sanofi | Heterocyclically substituted methoxyphenyl derivatives with an oxo group, processes for preparation thereof and use thereof as medicaments |
| NZ604423A (en) | 2010-06-24 | 2015-01-30 | Alkermes Pharma Ireland Ltd | Prodrugs of nh-acidic compounds: ester, carbonate, carbamate and phosphonate derivatives |
| US9156822B2 (en) | 2010-07-02 | 2015-10-13 | The University Of North Carolina At Chapel Hill | Functionally selective ligands of dopamine D2 receptors |
| US8623324B2 (en) | 2010-07-21 | 2014-01-07 | Aat Bioquest Inc. | Luminescent dyes with a water-soluble intramolecular bridge and their biological conjugates |
| HK1198628A1 (en) | 2011-08-12 | 2015-05-22 | Ascendis Pharma A/S | Polymeric hyperbranched carrier-linked prodrugs |
| EP2741779A1 (en) | 2011-08-12 | 2014-06-18 | Ascendis Pharma A/S | High-loading water-soluble carrier-linked prodrugs |
| WO2013088255A1 (en) | 2011-12-15 | 2013-06-20 | Alkermes Pharma Ireland Limited | Prodrugs of secondary amine compounds |
| BR112015003393A2 (pt) | 2012-08-16 | 2017-07-04 | Janssen Pharmaceutica Nv | pirazóis substituídos como bloqueadores de canal de cálcio de tipo-n |
| PL2888373T3 (pl) | 2012-08-21 | 2018-08-31 | Janssen Pharmaceutica Nv | Przeciwciała dla arypiprazolu i ich zastosowanie |
| ES2870004T3 (es) | 2012-08-21 | 2021-10-26 | Janssen Pharmaceutica Nv | Anticuerpos contra la risperidona y uso de los mismos |
| CA2882560C (en) * | 2012-08-21 | 2020-10-27 | Ortho-Clinical Diagnostics, Inc. | Haptens of risperidone and paliperidone for use in immunoassays |
| ES3057437T3 (en) | 2012-08-21 | 2026-03-02 | Janssen Pharmaceutica Nv | Antibodies to olanzapine haptens and use thereof |
| WO2014031584A1 (en) | 2012-08-21 | 2014-02-27 | Janssen Pharmaceutica Nv | Haptens of aripiprazole and their use in immunoassays |
| AU2013305930B2 (en) | 2012-08-21 | 2017-08-24 | Saladax Biomedical Inc. | Haptens of paliperidone |
| WO2014031645A1 (en) | 2012-08-21 | 2014-02-27 | Ortho-Clinical Diagnostics, Inc | Antibodies to risperidone haptens and use thereof |
| PT3305784T (pt) | 2012-08-21 | 2020-10-23 | Janssen Pharmaceutica Nv | Haptenos de quetiapina para utilização em ensaios imunológicos |
| ES2654413T3 (es) | 2012-08-21 | 2018-02-13 | Janssen Pharmaceutica, N.V. | Anticuerpos a quetiapina y uso de los mismos |
| JP2015529199A (ja) | 2012-08-21 | 2015-10-05 | オルソ−クリニカル ダイアグノスティクス,インコーポレイティド | パリペリドンハプテンに対する抗体及びその使用 |
| PL2888286T3 (pl) | 2012-08-21 | 2018-07-31 | Janssen Pharmaceutica Nv | Przeciwciała skierowane przeciwko haptenom kwetiapinowym i ich zastosowanie |
| AU2013305970B2 (en) | 2012-08-21 | 2017-08-17 | Saladax Biomedical Inc. | Antibodies to aripiprazole haptens and use thereof |
| ES2701062T3 (es) | 2012-08-21 | 2019-02-20 | Janssen Pharmaceutica Nv | Haptenos de olanzapina |
| WO2014031662A2 (en) | 2012-08-21 | 2014-02-27 | Ortho-Clinical Diagnostics, Inc | Antibodies to olanzapine and use thereof |
| EP2888277A4 (en) | 2012-08-21 | 2016-05-18 | Ortho Clinical Diagnostics Inc | ANTIBODIES AGAINST PALIPERIDONE AND USE THEREOF |
| US9453002B2 (en) | 2013-08-16 | 2016-09-27 | Janssen Pharmaceutica Nv | Substituted imidazoles as N-type calcium channel blockers |
| JP6949025B2 (ja) * | 2015-12-17 | 2021-10-13 | ヤンセン ファーマシューティカ エヌ.ベー. | リスペリドンに対する抗体及びその使用 |
| CN108368180B (zh) | 2015-12-17 | 2022-07-26 | 詹森药业有限公司 | 喹硫平的抗体及其用途 |
-
2013
- 2013-08-20 WO PCT/US2013/055794 patent/WO2014031645A1/en not_active Ceased
- 2013-08-20 JP JP2015528590A patent/JP6374387B2/ja active Active
- 2013-08-20 US US13/971,475 patent/US9751953B2/en active Active
- 2013-08-20 EP EP13830253.4A patent/EP2888284B1/en active Active
- 2013-08-20 ES ES13830253T patent/ES2926662T3/es active Active
- 2013-08-20 CA CA2882563A patent/CA2882563C/en active Active
- 2013-08-20 PT PT138302534T patent/PT2888284T/pt unknown
- 2013-08-20 CN CN201810382955.6A patent/CN108517014A/zh active Pending
- 2013-08-20 CN CN201380054952.5A patent/CN104736565B/zh active Active
- 2013-08-20 AU AU2013305884A patent/AU2013305884B2/en active Active
- 2013-08-20 PL PL13830253.4T patent/PL2888284T3/pl unknown
-
2017
- 2017-09-01 US US15/694,609 patent/US10793644B2/en active Active
-
2018
- 2018-01-05 AU AU2018200107A patent/AU2018200107B2/en active Active
- 2018-07-19 JP JP2018135531A patent/JP6971927B2/ja active Active
-
2019
- 2019-12-23 AU AU2019284059A patent/AU2019284059B2/en active Active
-
2020
- 2020-09-08 JP JP2020150207A patent/JP2021003118A/ja active Pending
- 2020-09-09 US US16/948,230 patent/US20200399400A1/en not_active Abandoned
Patent Citations (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO1999040934A1 (en) * | 1998-02-12 | 1999-08-19 | Immune Complex, Corporation | Strategically modified hepatitis b core proteins and their derivatives |
| CN1496974A (zh) * | 2002-01-31 | 2004-05-19 | ʵ | 氯胺酮和其代谢物的半抗原、免疫原、抗体和偶联物 |
| CN101147063A (zh) * | 2005-02-08 | 2008-03-19 | 萨拉戴克斯生物医学公司 | 5-氟-尿嘧啶免疫测定 |
| JP2008094729A (ja) * | 2006-10-06 | 2008-04-24 | Osaka Prefecture Univ | ハプテン化合物および抗体 |
| US20110229979A1 (en) * | 2010-03-16 | 2011-09-22 | Salamone Salvatore J | Risperidone immunoassay |
| CN101987836A (zh) * | 2010-08-31 | 2011-03-23 | 华南农业大学 | 氯丙嗪半抗原、人工抗原和抗体及其制备方法和应用 |
Non-Patent Citations (2)
| Title |
|---|
| MARVIN H. GOODROW等: "Strategies for immunoassay hapten design", 《ACS SYMPOSIUM SERIES》 * |
| ZEINAB A. EL-SHERIF等: "High performance liquid chromatographic and thin layer densitometric methods for the determination of risperidone in the presence of its degradation products in bulk powder and in tablets", 《JOURNAL OF PHARMACEUTICAL AND BIOMEDICAL ANALYSIS》 * |
Cited By (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN113424060A (zh) * | 2019-01-31 | 2021-09-21 | 美国西门子医学诊断股份有限公司 | 抗纳洛酮和抗纳曲酮单克隆抗体及其生产和使用方法 |
| CN113424060B (zh) * | 2019-01-31 | 2024-11-26 | 美国西门子医学诊断股份有限公司 | 抗纳洛酮和抗纳曲酮单克隆抗体及其生产和使用方法 |
| US12404346B2 (en) | 2019-01-31 | 2025-09-02 | Siemens Healthcare Diagnostics Inc. | Anti-naloxone and anti-naltrexone monoclonal antibodies and methods of production and use thereof |
| CN112608310A (zh) * | 2020-12-17 | 2021-04-06 | 北京丹大生物技术有限公司 | 一种利培酮和9-羟基利培酮半抗原、抗原和抗体以及其应用 |
| CN116003404A (zh) * | 2022-12-14 | 2023-04-25 | 杭州同舟生物技术有限公司 | 一种利培酮人工半抗原、人工抗原及其制备方法和应用 |
| CN116003404B (zh) * | 2022-12-14 | 2024-10-01 | 杭州同舟生物技术有限公司 | 一种利培酮人工半抗原、人工抗原及其制备方法和应用 |
Also Published As
| Publication number | Publication date |
|---|---|
| CA2882563A1 (en) | 2014-02-27 |
| EP2888284A1 (en) | 2015-07-01 |
| AU2018200107A1 (en) | 2018-01-25 |
| WO2014031645A1 (en) | 2014-02-27 |
| US20140057301A1 (en) | 2014-02-27 |
| JP2015532646A (ja) | 2015-11-12 |
| JP2019001788A (ja) | 2019-01-10 |
| CN104736565B (zh) | 2019-03-12 |
| HK1211957A1 (en) | 2016-06-03 |
| CA2882563C (en) | 2022-11-29 |
| AU2018200107B2 (en) | 2019-10-03 |
| AU2013305884B2 (en) | 2017-10-05 |
| US20180022827A1 (en) | 2018-01-25 |
| ES2926662T3 (es) | 2022-10-27 |
| AU2019284059B2 (en) | 2022-03-10 |
| PT2888284T (pt) | 2022-11-18 |
| US20200399400A1 (en) | 2020-12-24 |
| PL2888284T3 (pl) | 2023-02-27 |
| US10793644B2 (en) | 2020-10-06 |
| US9751953B2 (en) | 2017-09-05 |
| EP2888284A4 (en) | 2016-03-30 |
| JP6971927B2 (ja) | 2021-11-24 |
| EP2888284B1 (en) | 2022-07-06 |
| JP6374387B2 (ja) | 2018-08-15 |
| JP2021003118A (ja) | 2021-01-14 |
| CN104736565A (zh) | 2015-06-24 |
| AU2019284059A1 (en) | 2020-01-23 |
| AU2013305884A1 (en) | 2015-03-05 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN104736565B (zh) | 利培酮半抗原的抗体及其用途 | |
| CN104736564B (zh) | 喹硫平半抗原的抗体及其用途 | |
| US11105793B2 (en) | Antibodies to aripiprazole haptens and use thereof | |
| AU2018200435B2 (en) | Antibodies to olanzapine haptens and use thereof | |
| JP6131500B2 (ja) | リスペリドン及びパリペリドンのハプテン | |
| JP6286429B2 (ja) | パリペリドンのハプテン | |
| JP6131414B2 (ja) | アリピプラゾールのハプテン及びイムノアッセイにおけるそれらの使用 | |
| CN104736566A (zh) | 帕潘立酮半抗原的抗体及其用途 | |
| HK1211955B (en) | Antibodies to aripiprazole haptens and use thereof |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PB01 | Publication | ||
| PB01 | Publication | ||
| SE01 | Entry into force of request for substantive examination | ||
| SE01 | Entry into force of request for substantive examination |